Our teams: OPPaLE
My primary areas of focus predominantly revolve around prematurity, with a particular emphasis on its obstetrical context and how it influences neonatal and child outcomes. Additionally, I delve into neonatal encephalopathy, exploring obstetrical risk factors and the effects of healthcare quality. Lastly, I examine maternal morbidity, specifically within the placenta accreta spectrum and the risk factors of post-partum haemorrhage.
Research interests
- Prematurity, chorioamnionitis, premature rupture of membranes, mode of delivery
- Hypoxic ischemic encephalopathy
- Placenta accreta spectrum, post partum hemorrhage
Key publications
- Kayem G, Seco A, Beucher G, Dupont C, Branger B, Crenn Hebert C, et al. Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study. BJOG. 2021;128(10):1646-55.
View publication - Kayem G, Doloy A, Schmitz T, Chitrit Y, Bouhanna P, Carbonne B, et al. Antibiotics for amniotic-fluid colonization by Ureaplasma and/or Mycoplasma spp. to prevent preterm birth: A randomized trial. PLoS One. 2018;13(11):e0206290.
View publication - Lorthe E, Letouzey M, Torchin H, Foix L'Helias L, Gras-Le Guen C, Benhammou V, Charlier C, Kayem G. Antibiotic prophylaxis in preterm premature rupture of membranes at 24-31 weeks' gestation: Perinatal and 2-year outcomes in the EPIPAGE-2 cohort. BJOG. 2022;129(9):1560-73.
View publication
